Therapeutic potential of RNA interference against cancer
about
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic interventionGene therapy for cardiovascular disease mediated by ultrasound and microbubbles.Photomechanical wave-driven delivery of siRNAs targeting intermediate filament proteins promotes functional recovery after spinal cord injury in ratsLocal delivery of reporter gene to the cochlea does not spread to brain tissue in an animal model.Functional delivery of siRNA in mice using dendriworms.Modeling RNA interference in mammalian cellsImage-guided breast tumor therapy using a small interfering RNA nanodrugActivated PKC{delta} and PKC{epsilon} inhibit epithelial chloride secretion response to cAMP via inducing internalization of the Na+-K+-2Cl- cotransporter NKCC1Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer.RNAi therapeutics: principles, prospects and challenges.Local applications of myostatin-siRNA with atelocollagen increase skeletal muscle mass and recovery of muscle functionEnhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides.RNA interference targeting enhancer of polycomb1 exerts anti-tumor effects in lung cancer.Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer.Lentivirus-Mediated Short-Hairpin RNA Targeting Protein Phosphatase 4 Regulatory Subunit 1 Inhibits Growth in Breast Cancer.Delivery of intracellular-acting biologics in pro-apoptotic therapies.TNF-α gene knockout in triple negative breast cancer cell line induces apoptosis.Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression.Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcomaGlutathione S-transferase Pi mediates proliferation of androgen-independent prostate cancer cellsEthical perspectives on RNA interference therapeutics.Interfering with disease: a progress report on siRNA-based therapeutics.Allele dependent silencing of COL1A2 using small interfering RNAsNonviral delivery of synthetic siRNAs in vivo.Multi-target siRNA: Therapeutic Strategy for Hepatocellular Carcinoma.Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy.Pharmacokinetic considerations regarding non-viral cancer gene therapy.Allele dependent silencing of collagen type I using small interfering RNAs targeting 3'UTR Indels - a novel therapeutic approach in osteogenesis imperfecta.Concepts in in vivo siRNA delivery for cancer therapy.Alkane-modified short polyethyleneimine for siRNA deliveryA novel platform to enable inhaled naked RNAi medicine for lung cancer.Nonviral methods for siRNA deliveryLipid-based systemic delivery of siRNA.RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside.Strategies for short hairpin RNA delivery in cancer gene therapy.Lipid-based nanotherapeutics for siRNA deliveryStrategies for tumor-directed delivery of siRNA.Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
P2860
Q24669624-F1FAF6BB-97B1-4C34-BE62-15DD00739D19Q28080281-13FBB260-B95D-414F-AB3B-3FBE3ED82072Q30454594-56B0CB16-9DAB-4114-A3A9-A569A9A90661Q30459711-CC4F5D0C-6D10-4233-9D14-488EC2A7584EQ33447441-C9BF61EA-29B9-48E8-AA80-BD7B85218C7DQ33686651-9F4CC3AD-F65E-42D9-8F60-F16AECA6B78AQ33805528-B40DCA11-5D17-410D-A188-A6B33B0FF5ACQ34168738-78281E4B-FCA8-46C0-9531-0B9C1D7F0EC8Q34232130-4565E3F8-5610-4923-B440-6B2DDD302966Q34458532-1A6D7B0F-6189-4924-89A6-FD9ABEB7176BQ34621268-E0954A12-1F12-4CB3-BC97-66460B3F086AQ34746296-ADCEAB9E-050E-4B2E-8C89-12F4F57F1B42Q35087556-DADCDDC7-C49B-4E0D-9FC1-E38821C15E02Q35144924-A8EB5595-4D07-4CA6-9A26-30BE28AF71C7Q35947017-8CD224B1-FE5E-4376-8DE8-B65404781BADQ36119526-6854F4C9-EE44-4284-B5E6-3CEBE9C4E41AQ36145692-992C6D86-A934-4361-956D-931BDF4174A2Q36588920-4CE96741-31CA-467A-9C73-E88CEC7F395FQ36589909-D70CA5E3-C37B-44E3-874B-4EC484C6705EQ36659255-0BC9E817-8E1D-4AFC-91DD-B051931D5944Q36663577-363F85EC-0884-4D67-843F-6D7F3C021B18Q36743636-4B0AD9C6-6DA0-487D-85DD-857263605569Q36743751-A0BBA5C5-9E3A-49A0-8AD1-D7838EA58B0EQ36836598-40F9CACB-2848-42AB-A613-B1B532EEBE39Q36973764-85417123-0450-4544-8B29-A88CB7D73854Q37024768-CC181811-197C-4E74-A644-64D47E209044Q37068023-BC95B452-DDF7-4D62-B0C4-236D70A2576FQ37069628-AFF00E61-5974-4E07-8A01-3FAB21BF671BQ37092309-7F024005-F3D6-4C01-89CB-77AC83339DC0Q37119320-3CB018A8-0CE0-4C78-9FCC-FD62F3CEDCF4Q37217876-C789524E-1574-4208-83C0-E0477C409280Q37270658-30033115-C7D6-4F2D-AA73-EC988DBB0F0CQ37338963-72B40AC6-FC9C-453F-A30C-72BE77EBF0F1Q37360226-4A8D052A-B286-4E55-8EBC-FC63BF7186D7Q37425606-B7EAAFD3-D585-4F39-AB6C-BA9B21924D3AQ37566034-EAE12ADA-454A-437E-82D8-84088C636C0CQ37598928-112BD621-0E1E-4475-86BF-CCF56F6D530CQ37670986-CA39B989-38CA-438D-BF47-195E88B1B375Q37840092-7EA0497E-ED32-4815-917B-E93F3B5D2656Q37849461-76E60C76-3D5C-4D5E-BAF2-A72DB474122D
P2860
Therapeutic potential of RNA interference against cancer
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Therapeutic potential of RNA interference against cancer
@ast
Therapeutic potential of RNA interference against cancer
@en
Therapeutic potential of RNA interference against cancer
@nl
type
label
Therapeutic potential of RNA interference against cancer
@ast
Therapeutic potential of RNA interference against cancer
@en
Therapeutic potential of RNA interference against cancer
@nl
prefLabel
Therapeutic potential of RNA interference against cancer
@ast
Therapeutic potential of RNA interference against cancer
@en
Therapeutic potential of RNA interference against cancer
@nl
P2860
P3181
P1433
P1476
Therapeutic potential of RNA interference against cancer
@en
P2093
Fumitaka Takeshita
Takahiro Ochiya
P2860
P304
P3181
P356
10.1111/J.1349-7006.2006.00234.X
P407
P577
2006-08-01T00:00:00Z